Quick Answer
NANOVIRICIDES, INC. reported Diluted EPS of $0.63 per share (loss) for fiscal year 2025.
NANOVIRICIDES, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.63 | +10.0% |
| 2024 | -$0.70 | +5.4% |
| 2023 | -$0.74 | -5.7% |
| 2022 | -$0.70 | +13.6% |
| 2021 | -$0.81 | -523.1% |
| 2018 | -$0.13 | +23.5% |
| 2017 | -$0.17 | +10.5% |
| 2016 | -$0.19 | -111.1% |
| 2015 | -$0.09 | +66.7% |
| 2014 | -$0.27 | -42.1% |
| 2013 | -$0.19 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$0.11 | +21.4% | -10.0% |
| September 30, 2025 | -$0.10 | +56.5% | +28.6% |
| March 31, 2025 | -$0.14 | +12.5% | +0.0% |
| December 31, 2024 | -$0.14 | +22.2% | +39.1% |
| September 30, 2024 | -$0.23 | -35.3% | -43.8% |
| March 31, 2024 | -$0.16 | -6.7% | +11.1% |
| December 31, 2023 | -$0.18 | -20.0% | -5.9% |
| September 30, 2023 | -$0.17 | -21.4% | -13.3% |
- NANOVIRICIDES, INC. showed an increase of +10.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2013–2025 period, NANOVIRICIDES, INC.’s diluted eps has declined by 231.6% (from $0.19 per share (loss) to $0.63 per share (loss)).
- The most recent figure is from NANOVIRICIDES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: